| Outgoing Relation(s) |
| dopaminergic antagonist (CHEBI:48561) is a antagonist (CHEBI:48706) |
| dopaminergic antagonist (CHEBI:48561) is a dopaminergic agent (CHEBI:48560) |
| Incoming Relation(s) |
| (+)-butaclamol (CHEBI:73298) has role dopaminergic antagonist (CHEBI:48561) |
| (S)-(−)-sulpiride (CHEBI:64119) has role dopaminergic antagonist (CHEBI:48561) |
| (1S,2R)-5-methoxy-1-methyl-2-(propylamino)tetralin (CHEBI:64117) has role dopaminergic antagonist (CHEBI:48561) |
| (1S,2R)-5-methoxy-1-methyl-2-(propylamino)tetralin hydrochloride (CHEBI:64115) has role dopaminergic antagonist (CHEBI:48561) |
| cis-flupenthixol (CHEBI:10454) has role dopaminergic antagonist (CHEBI:48561) |
| amoxapine (CHEBI:2675) has role dopaminergic antagonist (CHEBI:48561) |
| asenapine (CHEBI:71253) has role dopaminergic antagonist (CHEBI:48561) |
| asenapine maleate (CHEBI:71245) has role dopaminergic antagonist (CHEBI:48561) |
| azaperone (CHEBI:88301) has role dopaminergic antagonist (CHEBI:48561) |
| carfenazine (CHEBI:51235) has role dopaminergic antagonist (CHEBI:48561) |
| carphenazine maleate (CHEBI:51241) has role dopaminergic antagonist (CHEBI:48561) |
| chlorpromazine (CHEBI:3647) has role dopaminergic antagonist (CHEBI:48561) |
| chlorprothixene (CHEBI:3651) has role dopaminergic antagonist (CHEBI:48561) |
| chlorprothixene hydrochloride (CHEBI:180502) has role dopaminergic antagonist (CHEBI:48561) |
| clopenthixol (CHEBI:59115) has role dopaminergic antagonist (CHEBI:48561) |
| clozapine (CHEBI:3766) has role dopaminergic antagonist (CHEBI:48561) |
| domperidone (CHEBI:31515) has role dopaminergic antagonist (CHEBI:48561) |
| domperidone maleate (CHEBI:59812) has role dopaminergic antagonist (CHEBI:48561) |
| droperidol (CHEBI:4717) has role dopaminergic antagonist (CHEBI:48561) |
| fenoldopam (CHEBI:5002) has role dopaminergic antagonist (CHEBI:48561) |
| flupenthixol (CHEBI:5121) has role dopaminergic antagonist (CHEBI:48561) |
| fluphenazine (CHEBI:5123) has role dopaminergic antagonist (CHEBI:48561) |
| fluphenazine decanoate (CHEBI:5124) has role dopaminergic antagonist (CHEBI:48561) |
| haloperidol (CHEBI:5613) has role dopaminergic antagonist (CHEBI:48561) |
| iloperidone (CHEBI:65173) has role dopaminergic antagonist (CHEBI:48561) |
| loxapine (CHEBI:50841) has role dopaminergic antagonist (CHEBI:48561) |
| lurasidone (CHEBI:70735) has role dopaminergic antagonist (CHEBI:48561) |
| lurasidone hydrochloride (CHEBI:70732) has role dopaminergic antagonist (CHEBI:48561) |
| mesoridazine (CHEBI:6780) has role dopaminergic antagonist (CHEBI:48561) |
| mesoridazine besylate (CHEBI:6781) has role dopaminergic antagonist (CHEBI:48561) |
| methiothepin (CHEBI:64203) has role dopaminergic antagonist (CHEBI:48561) |
| methiothepin maleate (CHEBI:64202) has role dopaminergic antagonist (CHEBI:48561) |
| methotrimeprazine (CHEBI:6838) has role dopaminergic antagonist (CHEBI:48561) |
| metoclopramide (CHEBI:107736) has role dopaminergic antagonist (CHEBI:48561) |
| metoclopramide dihydrochloride monohydrate (CHEBI:60906) has role dopaminergic antagonist (CHEBI:48561) |
| metoclopramide hydrochloride (CHEBI:6899) has role dopaminergic antagonist (CHEBI:48561) |
| mosapramine (CHEBI:135775) has role dopaminergic antagonist (CHEBI:48561) |
| mosapramine dihydrochloride (CHEBI:31866) has role dopaminergic antagonist (CHEBI:48561) |
| nafadotride (CHEBI:64191) has role dopaminergic antagonist (CHEBI:48561) |
| nemonapride (CHEBI:31899) has role dopaminergic antagonist (CHEBI:48561) |
| olanzapine (CHEBI:7735) has role dopaminergic antagonist (CHEBI:48561) |
| paliperidone (CHEBI:82978) has role dopaminergic antagonist (CHEBI:48561) |
| paliperidone palmitate (CHEBI:83807) has role dopaminergic antagonist (CHEBI:48561) |
| perazine (CHEBI:59118) has role dopaminergic antagonist (CHEBI:48561) |
| perphenazine (CHEBI:8028) has role dopaminergic antagonist (CHEBI:48561) |
| pimozide (CHEBI:8212) has role dopaminergic antagonist (CHEBI:48561) |
| pipamperone (CHEBI:78549) has role dopaminergic antagonist (CHEBI:48561) |
| pipamperone dihydrochloride (CHEBI:32004) has role dopaminergic antagonist (CHEBI:48561) |
| prochlorperazine (CHEBI:8435) has role dopaminergic antagonist (CHEBI:48561) |
| promazine (CHEBI:8459) has role dopaminergic antagonist (CHEBI:48561) |
| propiomazine (CHEBI:8491) has role dopaminergic antagonist (CHEBI:48561) |
| quetiapine (CHEBI:8707) has role dopaminergic antagonist (CHEBI:48561) |
| risperidone (CHEBI:8871) has role dopaminergic antagonist (CHEBI:48561) |
| ritanserin (CHEBI:64195) has role dopaminergic antagonist (CHEBI:48561) |
| SCH 23390 (CHEBI:73297) has role dopaminergic antagonist (CHEBI:48561) |
| spiperone (CHEBI:9233) has role dopaminergic antagonist (CHEBI:48561) |
| spiramide (CHEBI:64207) has role dopaminergic antagonist (CHEBI:48561) |
| sulpiride (CHEBI:32168) has role dopaminergic antagonist (CHEBI:48561) |
| tetrahydropalmatine (CHEBI:16563) has role dopaminergic antagonist (CHEBI:48561) |
| thiethylperazine (CHEBI:9544) has role dopaminergic antagonist (CHEBI:48561) |
| thiopropazate (CHEBI:59119) has role dopaminergic antagonist (CHEBI:48561) |
| thioridazine (CHEBI:9566) has role dopaminergic antagonist (CHEBI:48561) |
| trifluoperazine (CHEBI:45951) has role dopaminergic antagonist (CHEBI:48561) |
| triflupromazine (CHEBI:9711) has role dopaminergic antagonist (CHEBI:48561) |
| ziprasidone (CHEBI:10119) has role dopaminergic antagonist (CHEBI:48561) |
| zuclopenthixol (CHEBI:51364) has role dopaminergic antagonist (CHEBI:48561) |
